Sandoz announced today that Sandoz Japan has received marketing authorization approval for its biosimilar filgrastim (Kyowa Hakko Kirin's GRAN®). The product, which will be marketed as Filgrastim BS ...

New Granix Syringes Approved for Self-Administration Teva Oncology announced the launch of a new single-use pre-filled syringe for self-administration for Granix (tbo-filgrastim). Teva Oncology ...

The nature of their application and their mode of use mean that prefilled syringes meet the regulatory definitions of immediate packaging or container–closure systems. Prefilled syringes have become ...

Sandoz Filgrastim approved in all indications as the reference product Sandoz becomes first company to secure approval for two biosimilars in Japan Approval marks continued expansion of Sandoz' ...